Trintellix (vortioxetine) / Lundbeck, Takeda  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Trintellix (vortioxetine) / Lundbeck, Takeda
NCT04498897: Vortioxetine for Treatment of Depressive Mood and Alcohol Use

Recruiting
2
128
RoW
Vortioxetine, Acamprosate
Hanyang University Seoul Hospital
Depressive Disorder, Major, Alcoholism
04/21
04/21
2019-001836-69: Treatment of Patients with Mild Cognitive Impairment measuring Brain Function with Functional Magnetic Resonance Imaging

Not yet recruiting
2
45
Europe
Vortioxetine, Capsule, hard, Brintellix 10mg, Brintellix 20mg
Medical University of Vienna, Medical University of Vienna
Mild cognitive impairment, Mild cognitive impairment, Diseases [C] - Nervous System Diseases [C10]
 
 
NCT05047952: Vortioxetine for Post-COVID-19 Condition

Completed
2
200
Canada
Vortioxetine, Placebo
Brain and Cognition Discovery Foundation
Post-COVID-19 Condition, Post-COVID-19 Syndrome, Cognitive Impairment
02/23
02/23
STAMD, NCT05814640: Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)

Recruiting
1/2
520
RoW
Fluoxetine, Sertraline, Vortioxetine, Duloxetine, Aripiprazole, Lithium Carbonate, Olanzapine, GCBT
First Affiliated Hospital of Chongqing Medical University, The Second Affiliated Hospital of Chongqing Medical University, Children's Hospital of Chongqing Medical University, Southwest Hospital, China, Central South University
Depression, Sequestra
12/25
07/27

Download Options